InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,474.22
(
0.02%
)
US TECH 100
19,276.80
(
0.09%
)
Dow Jones
39,124.70
(
-0.03%
)
Brent Oil
84.41
(
-0.71%
)
Bitcoin
63,646.11
(
-1.81%
)
Post# of 1739
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

cash_cow1

Send PM Follow Ignore
Followers 5
Posts 809
Boards Moderated 0
Alias Born 08/30/2017

cash_cow1

Re: ADVFN_bioking post# 1363

Wednesday, 11/13/2019 9:43:52 AM

Wednesday, November 13, 2019 9:43:52 AM

Post# of 1739
Evoke Pharma Inc Granted 180 NASDAQ Extension until May 11, 2020. Evoke Pharma provided a written response to the Qualification Department of the NASDAQ stock market outlining planned NDA Resubmission this quarter.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent EVOK News
More EVOK News
InvestorsHub NewsWire

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

Start posting your company's news
Only $200 per official company press release!